Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |